TVRAX
Price
$18.75
Change
-$0.15 (-0.79%)
Updated
Jul 13 closing price
Net Assets
201.37M
VIGAX
Price
$266.06
Change
-$3.87 (-1.43%)
Updated
Jul 13 closing price
Net Assets
379.21B
Interact to see
Advertisement

TVRAX vs VIGAX

TVRAX vs VIGAX Comparison Chart in %
View a ticker or compare two or three
VS
TVRAX vs. VIGAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TVRAX is a StrongBuy and VIGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 379B vs. TVRAX (201M). TVRAX pays higher dividends than VIGAX: TVRAX (0.67) vs VIGAX (0.38). TVRAX was incepted earlier than VIGAX: TVRAX (14 years) vs VIGAX (26 years). TVRAX (1.52) is less costly to investors than VIGAX (0.05). TVRAX is a more actively managed with annual turnover of: 87.00 vs. VIGAX (12.00). TVRAX has a lower initial minimum investment than VIGAX: TVRAX (2500) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 18.72 vs. TVRAX (10.05). VIGAX return over 5 years is better than : 78.70 vs. TVRAX (7.25).
TVRAXVIGAXTVRAX / VIGAX
Total Expense Ratio1.470.052,940%
Annual Report Gross Expense Ratio1.520.053,040%
Fund Existence14 years26 years-
Gain YTD10.4627.482140%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets201M379B0%
Annual Yield % from dividends0.670.38177%
Returns for 1 year10.0518.7254%
Returns for 3 years31.9581.3639%
Returns for 5 years7.2578.709%
Returns for 10 years47.02374.9213%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTMUX25.99N/A
N/A
Goldman Sachs Small/Mid Cap Growth R6
VLCAX175.58N/A
N/A
Vanguard Large Cap Index Admiral
MASKX32.18N/A
N/A
iShares Russell 2000 Small-Cap Idx Instl
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I